Literature DB >> 20381273

E. coli-mediated gut inflammation in genetically predisposed Crohn's disease patients.

N Barnich1, J Denizot, A Darfeuille-Michaud.   

Abstract

Many advances have been made in the understanding of Crohn's disease (CD) pathogenesis over the last decade. In CD patients abnormal ileal bacterial colonization could be linked to inappropriate innate immune responses to invasive bacteria. Adherent and invasive Escherichia coli strains have been isolated from CD patients and are able to adhere to and to invade intestinal epithelial cells and to induce colitis in transgenic mice expressing the human CEACAM6 molecule. In this review, we report recent advances concerning the involvement of adherent-invasive E. coli in the aetiology of CD and analyze how they can initiate inflammation of the gut mucosa in individuals with genetic predisposition.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CEACAM6; Crohn’ disease; E. coli; Genetic predisposition; Maladie de Crohn; Prédisposition génétique

Mesh:

Substances:

Year:  2010        PMID: 20381273     DOI: 10.1016/j.patbio.2010.01.004

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  12 in total

1.  Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes.

Authors:  Patrick Veiga; Carey Ann Gallini; Chloé Beal; Monia Michaud; Mary L Delaney; Andrea DuBois; Artem Khlebnikov; Johan E T van Hylckama Vlieg; Shivesh Punit; Jonathan N Glickman; Andrew Onderdonk; Laurie H Glimcher; Wendy S Garrett
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  IBD-what role do Proteobacteria play?

Authors:  Indrani Mukhopadhya; Richard Hansen; Emad M El-Omar; Georgina L Hold
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

3.  The gut microbiota of siblings offers insights into microbial pathogenesis of inflammatory bowel disease.

Authors:  Charlotte R Hedin; Christopher J van der Gast; Andrew J Stagg; James O Lindsay; Kevin Whelan
Journal:  Gut Microbes       Date:  2017-01-23

4.  The bowel microbiota and inflammatory bowel diseases.

Authors:  Gerald W Tannock
Journal:  Int J Inflam       Date:  2010-08-05

Review 5.  Proteobacteria: A Common Factor in Human Diseases.

Authors:  G Rizzatti; L R Lopetuso; G Gibiino; C Binda; A Gasbarrini
Journal:  Biomed Res Int       Date:  2017-11-02       Impact factor: 3.411

Review 6.  Tryptophan Metabolites Along the Microbiota-Gut-Brain Axis: An Interkingdom Communication System Influencing the Gut in Health and Disease.

Authors:  Annalisa Bosi; Davide Banfi; Michela Bistoletti; Cristina Giaroni; Andreina Baj
Journal:  Int J Tryptophan Res       Date:  2020-06-11

7.  Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseases.

Authors:  Pascale Blais Lecours; David Marsolais; Yvon Cormier; Marie Berberi; Chantal Haché; Raymond Bourdages; Caroline Duchaine
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

Review 8.  The gut microbiota and host health: a new clinical frontier.

Authors:  Julian R Marchesi; David H Adams; Francesca Fava; Gerben D A Hermes; Gideon M Hirschfield; Georgina Hold; Mohammed Nabil Quraishi; James Kinross; Hauke Smidt; Kieran M Tuohy; Linda V Thomas; Erwin G Zoetendal; Ailsa Hart
Journal:  Gut       Date:  2015-09-02       Impact factor: 23.059

Review 9.  Enteral Nutrition in Adult Crohn's Disease: Toward a Paradigm Shift.

Authors:  Simona Di Caro; Konstantinos C Fragkos; Katie Keetarut; Hui Fen Koo; Gregory Sebepos-Rogers; Hajeena Saravanapavan; John Barragry; Jennifer Rogers; Shameer J Mehta; Farooq Rahman
Journal:  Nutrients       Date:  2019-09-14       Impact factor: 5.717

10.  Metabolomic Signatures in Pediatric Crohn's Disease Patients with Mild or Quiescent Disease Treated with Partial Enteral Nutrition: A Feasibility Study.

Authors:  Jair Gonzalez Marques; Engy Shokry; Klara Frivolt; Katharina Julia Werkstetter; Annecarin Brückner; Tobias Schwerd; Sibylle Koletzko; Berthold Koletzko
Journal:  SLAS Technol       Date:  2020-11-18       Impact factor: 3.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.